AI in Quality Control: 3 Use Cases from Pharma Production

Why Quality Control Is the Best Starting Point for AI

Most life sciences companies want to deploy AI but don't know where to start. Our recommendation: start in quality control. Why? Because data availability is often best there, processes are clearly defined, and ROI becomes visible quickly.

Use Case 1: Visual Inspection of Tablets and Capsules

A mid-sized contract manufacturer in southern Germany automated the visual final inspection of its tablet production with an AI-powered camera system. Result: the defect detection rate increased from 94% to 99.7%. The false positive rate dropped by 60%, drastically reducing manual re-sorting effort. Payback period: 7 months.

The technical core: a convolutional neural network trained on 50,000 images of good and defective parts. The model detects cracks, discolorations, breakages, and shape deviations in real time - at a throughput rate of 120,000 units per hour.

Use Case 2: Deviation Detection in Process Monitoring

A specialty chemicals manufacturer uses AI-based anomaly detection in its batch production. The system monitors 47 process parameters (temperature, pressure, pH, stirring speed, etc.) and detects deviations before they lead to out-of-spec batches.

In the first 6 months, the system detected 12 potential OOS events early - 9 of which were prevented through timely corrective action. Estimated avoided damage: EUR 340,000 in discarded batches.

Use Case 3: Automated Release Documentation

Batch release is a time-intensive process in pharma production. A generics manufacturer partially automated release documentation: the AI system extracts relevant test results from LIMS, lab journals, and process data, creates a draft release report, and flags values outside specification.

The QP (Qualified Person) reviews and signs - but instead of 4 hours per batch, release now takes 45 minutes. With 200 batches per month, that's a significant capacity release.

What These Use Cases Have in Common

All three projects cost less than EUR 100,000 and paid for themselves within a year. None required a complete IT infrastructure overhaul. And all three were implemented GxP-compliant - with full validation documentation and audit trail.

The most important success factor was the same in every case: the companies started small, with a clearly defined use case, and only scaled after proof of value.